netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Upadacitinib found 14 matches
Open monograph to display formulary status BNF Category
  Upadacitinib  (Rinvoq®) Gastro-intestinal system - Drugs affecting the immune response - 01.05.03
  Upadacitinib  (Rinvoq®) Musculoskeletal and joint diseases - Cytokine modulators - 10.01.03
  Upadacitinib  (Rinvoq®) Skin - Drugs affecting the immune response - 13.05.03
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA665: Upadacitinib for treating severe rheumatoid arthritis (10.01.03)
link in drug section NICE TA744: Upadacitinib for treating moderate rheumatoid arthritis (10.01.03)
link in drug section NICE TA768: Upadacitinib for treating active psoriatic arthritis after inadequate response to DMARDs (10.01.03)
link in drug section NICE TA814: Abrocitinib, tralokinumab or upadacitinib for treating moderate to severe atopic dermatitis (10.01.03)
link in drug section NICE TA814: Abrocitinib, tralokinumab or upadacitinib for treating moderate to severe atopic dermatitis (13.05.03)
link in drug section NICE TA814: Abrocitinib, tralokinumab or upadacitinib for treating moderate to severe atopic dermatitis (13.05.03)
link in drug section NICE TA814: Abrocitinib, tralokinumab or upadacitinib for treating moderate to severe atopic dermatitis (13.05.03)
link in drug section NICE TA829: Upadacitinib for treating active ankylosing spondylitis (10.01.03)
link in drug section NICE TA856: Upadacitinib for treating moderately to severely active ulcerative colitis (01.05.03)
link in drug section NICE TA861: Upadacitinib for treating active non-radiographic axial spondyloarthritis (10.01.03)
link in drug section NICE TA905: Upadacitinib for previously treated moderately to severely active Crohn’s disease (01.05.03)


 
netFormulary